The CMS announced the launch of an Oncology Care Model that contains goals and incentives for practitioners in cancer care.
By Tony Hagen
Advertisement
Articles by By Tony Hagen
US-based global pharmaceuticals giant Pfizer Inc. will acquire Hospira Inc., a leading maker of sterile injectable drugs and infusion technologies, in a deal valued at $17 billion including debt.
Advertisement
Latest Updated Articles
Pfizer Expands Oncology Portfolio With $17 Billion Hospira AcquisitionPublished: February 5th 2015 | Updated:
New Oncology Care Model Reforms Payment System, Offers Performance-Based IncentivesPublished: February 13th 2015 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5